Detalhe da pesquisa
1.
[FIRST GENERATION PROTEASE INHIBITOR BASED TRIPLE THERAPY FOR HCV GENOTYPE 1--LOOKING BACK WHILE PROCEEDING TO A PROMISING ERA].
Harefuah
; 155(5): 272-5, 324, 323, 2016 05.
Artigo
em Hebraico
| MEDLINE | ID: mdl-27526553
2.
Efficacy and safety of sequential versus quadruple therapy as second-line treatment for helicobacter pylori infection-A randomized controlled trial.
PLoS One
; 12(9): e0183302, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28957341